The AUROC of plasma exosomal CAV1 were 0.76 (95% CI: 0.68-0.82) and 0.78 (95% CI: 0.70-0.84) for DFS and OS prediction in ovarian cancer patients, respectively. This evidence concerns the gene CAV1 and ovarian carcinoma.